These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 3809214)

  • 21. Further evidence for a dissociation of peripheral and central effects of vasopressin.
    Gaffori O; de Wied D
    Psychoneuroendocrinology; 1985; 10(4):439-44. PubMed ID: 4089084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Facilitation of arginine-vasopressin analogs on learning and memory in rats].
    Liu RY; Lin C; Du YC
    Zhongguo Yao Li Xue Bao; 1990 Mar; 11(2):97-100. PubMed ID: 2275398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of vasopressin and its analogs on blood coagulation in rats].
    Golubeva MG; Kalishevskaia TM; Solov'eva ME
    Fiziol Zh (1978); 1990; 36(3):25-30. PubMed ID: 2394244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MSH/ACTH4-10: a tool to differentiate between the role of vasopressin in memory consolidation or retrieval processes.
    van Wimersma Greidanus T
    Peptides; 1982; 3(1):7-11. PubMed ID: 6281748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specificity of aversive stimulus properties of vasopressin.
    Bluthé RM; Dantzer R; Mormède P; Le Moal M
    Psychopharmacology (Berl); 1985; 87(2):238-41. PubMed ID: 3931152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonally active arginine-vasopressin suppresses endotoxin-induced fever in rats: lack of effect of oxytocin and a behaviorally active vasopressin fragment.
    Kovács GL; De Wied D
    Neuroendocrinology; 1983 Oct; 37(4):258-61. PubMed ID: 6355890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-related influence of arginine-vasopressin on a passive avoidance behavior: effect of rearing conditions.
    Crine AF
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(3):379-84. PubMed ID: 6541358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasopressin antagonists block peripheral as well as central vasopressin receptors.
    De Wied D; Gaffori O; Van Ree JM; De Jong W
    Pharmacol Biochem Behav; 1984 Sep; 21(3):393-400. PubMed ID: 6093152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventive effect of cholecystokinin octapeptide on experimental amnesia in rats.
    Katsuura G; Itoh S
    Peptides; 1986; 7(1):105-10. PubMed ID: 3714527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neonatal administration of vasopressin antiserum induces long-term deficits on active and passive avoidance behaviour in rats.
    Moratalla R; Borrell J; Sanchez-Franco F; Del Rio J
    Behav Brain Res; 1987 Mar; 23(3):231-7. PubMed ID: 3580108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arginine vasopressin and a vasopressin antagonist peptide: opposite effects on extinction of active avoidance in rats.
    Koob GF; Le Moal M; Gaffori O; Manning M; Sawyer WH; Rivier J; Bloom FE
    Regul Pept; 1981 Jun; 2(3):153-63. PubMed ID: 7255768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Septal vasopressin modulates motility and passive avoidance in pinealectomized rats.
    Appenrodt E; Schwarzberg H
    Physiol Behav; 1999 Jul; 66(5):757-61. PubMed ID: 10405103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The participation of nitric oxide in the facilitator effect of arginine vasopressin on memory.
    Jachimowicz A; Hoły Z; Wiśniewski K
    Acta Neurobiol Exp (Wars); 1998; 58(1):37-45. PubMed ID: 9583186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No. 302, a newly synthesized [pGlu4,Cyt6]AVP(4-9) analogue, prevents the disruption of avoidance behavior.
    Hirate K; Hirano M; Nakajima Y; Hiyama A; Maeda O; Asakura W
    Behav Brain Res; 1997 Feb; 83(1-2):205-8. PubMed ID: 9062685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cysteinyl methyl ester of AVP(4-8), a potent agonist on the maintenance of passive avoidance in rats.
    Lin C; Liu RY; Du YC
    Peptides; 1990; 11(4):633-9. PubMed ID: 2235674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a single administration of oxytocin or vasopressin and their interactions with two selective receptor antagonists on memory storage in mice.
    Boccia MM; Kopf SR; Baratti CM
    Neurobiol Learn Mem; 1998 Mar; 69(2):136-46. PubMed ID: 9619993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ACTH-(4-9) analog ORG 2766 and desglycinamide9-(Arg8)-vasopressin reverse the retrograde amnesia induced by disrupting circadian rhythms in rats.
    Fekete M; Van Ree JM; De Wied D
    Peptides; 1986; 7(4):563-8. PubMed ID: 3020524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further in vivo evidence for antagonist-to-antidiuretic action of arginine vasopressin.
    Ishikawa S; Kim JK; Schrier RW
    Am J Physiol; 1983 Nov; 245(5 Pt 1):R713-9. PubMed ID: 6688929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The slowing of the extinction of a conditioned reaction and the antiamnesic action of arginine vasopressin and des-glycine-(8-arginine) vasopressin].
    Dubrovina NI; Papsuevich OS; Chipens GI
    Farmakol Toksikol; 1991; 54(5):5-7. PubMed ID: 1800150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of chronic vs. acute injection of vasopressin on animal learning and memory.
    Hamburger-Bar R; Klein A; Belmaker RH
    Peptides; 1985; 6(1):23-5. PubMed ID: 3991361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.